DNA-Targeted Auger Electron-Emitting Radiopharmaceuticals: Following the Short-Range High LET Path

Time: 2:15 pm
day: Day 1 Track A


  • The potential of short range high LET radioligand therapies is a hot topic as demonstrated by high scientific interest and investment in alpha-emitting drugs
  • Auger electrons are another class of high LET emission. The potential of an Auger emitter radioligand has been proposed for a several years, but combination with the correct protein target
    is crucial for success
  • An update of progress in the field and from Theragnostics’ work will be presented